|
Business news in brief
CINCINNATI P&G buys skin products line Procter & Gamble Co. said Monday it has bought HDS Cosmetics Lab Inc. from North Castle Partners, a private equity firm based in Greenwich, Conn. The companies did not disclose details of the transaction. P&G officials said the acquisition is part of its corporate strategy of focusing on skin care as a major growth category. HDS manufactures and markets the Doctor's Dermatologic Formula skin care line, created in 1991 by New York City dermatologist Dr. Howard Sobel. It includes products for anti-aging, acne, hyper-pigmentation and sun protection. The products are sold in select spas and in specialty retail and department stores. CINCINNATI 4,000 U.S. jobs cut Wolseley PLC, a British-based distributor and installer of building supplies, said Monday it eliminated about 4,000 jobs from August through December 2006 because of the downturn in U.S.
Breakthrough Acne Treatment Allows Users to Adjust Medication Strength
Even by middle age, a full 12 percent of women and 3 percent of men experience clinically significant acne. Thirty-percent of its victims also meet the diagnostic criteria for depression, anxiety, and suicide risk. And, the effects can be lifelong for the third of all acne sufferers who experience permanent facial scarring. For those with acne, their biggest challenge is that most acne treatments, though powerful therapies, are irritating, and add fuel to the inflammatory fire already burning inside their acne-affected skin. The seemingly insurmountable challenge for skincare formulators has been to develop an effective acne treatment that works across a broad range of skin types. The AcneRecovery system is based on the scientific premise that human skin is a very dynamic organ, constantly changing depending on a host of factors--personal health and hygiene, fluctuating hormones, surrounding environment, stress levels, et cetera This innovative delivery system allows the user to easily adjust the strength of the active medications up or down, for maximum acne treatment while minimizing skin irritation, redness, dryness and discomfort.
U.S. FDA OKs Bayer Oral Contraceptive
The U.S. Food and Drug Administration has approved a new use of Bayer Schering Pharma AG's drug YAZ to allow it to be used to treat moderate acne in women who also want to use an oral contraceptive for birth control, the company said Monday. With the approval, YAZ becomes the first oral contraceptive approved by the FDA for three distinct uses, Bayer said in a statement. In addition to being approved for birth control use and now for acne control, it is also approved to treat the emotional and physical symptoms of premenstrual dysphoric disorder. "YAZ is the fastest growing oral contraceptive brand in the U.S.," said Phil Smits, head of Bayer Schering Pharma's women's healthcare unit. "We are convinced that through its unique features, YAZ will further strengthen our worldwide leading market position in the field of female contraception." .
|